Authors: GLATTER KA DOROSTKAR P CHENG J SCHEINMAN MM

Citation: Ka. Glatter et al., USE OF IBUTILIDE TO TERMINATE ATRIAL-FIBRILLATION IN PATIENTS WITH ACCESSORY PATHWAYS, Circulation, 98(17), 1998, pp. 525-525

Authors: GLATTER KA CHATTERJEE K HUANG S CHENG J KAYSER S SCHEINMAN MM

Citation: Ka. Glatter et al., IS IT SAFE TO USE INTRAVENOUS IBUTILIDE IN PATIENTS RECEIVING CHRONICAMIODARONE THERAPY, Circulation, 98(17), 1998, pp. 4417-4417

Authors: GLATTER KA CHENG J TALWAR S ALNIMRI M LEE RJ SCHEINMAN MM

Citation: Ka. Glatter et al., COMPARISON OF ADENOSINE EFFECTS IN PATIENTS WITH FOCAL ATRIAL AND INAPPROPRIATE SINUS TACHYCARDIAS, Circulation, 96(8), 1997, pp. 3944-3944

Authors: GLATTER KA GRAVES SW HOLLENBERG NK SOSZYNSKI PA TAO QF FREM GJ WILLIAMS GH LAZARUS JM

Citation: Ka. Glatter et al., SUSTAINED VOLUME EXPANSION AND [NA,K]ATPASE INHIBITION IN CHRONIC-RENAL-FAILURE, American journal of hypertension, 7(11), 1994, pp. 1016-1025

Authors: GRAVES SW GLATTER KA LAZARUS JM WILLIAMS GH HOLLENBERG NK

Citation: Sw. Graves et al., VOLUME EXPANSION IN RENAL-FAILURE PATIENTS - A PARADIGM FOR A CLINICALLY RELEVANT [NA,K]ATPASE INHIBITOR, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000054-190000057